Related Experiment Video
Updated: Jan 10, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
Metabolic and Alcohol-Associated: Diagnosis and Management
Rahul Sandella1, Mary E Rinella2
1Department of Internal Medicine, University of Chicago Medicine, Chicago, IL, USA. Electronic address: https://twitter.com/RahulSandella.
Abstract:
Metabolic and alcohol/associated liver disease was introduced as a new term to describe those with steatotic liver disease who meet criteria for metabolic dysfunction-associated steatotic liver disease but exceed the allowable limits for alcohol within an upper limit of the equivalent of 50 to 60 g for females and males, respectively. Consumption beyond these limits would be characterized as alcohol-associated liver disease. Clinicians should focus on alcohol cessation counseling, metabolic risk factor management, as well as early referral to hepatology in those suspected to have significant fibrosis.
More Related Videos
08:37Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
07:31Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
Published on: January 7, 2019
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes: Symptoms, Diagnosis, and Complications
Inborn Errors of Metabolism
Chronic Pancreatitis II: Collaborative Care
Assessment: